Inhibitors of HIV-1 capsid formation: substituted aryl aminomethyl thiazole ureas and analogues thereof

Details for Australian Patent Application No. 2005304646 (hide)

Owner Achillion Pharmaceuticals, Inc. University Of Maryland

Inventors Chen, Xi; Summers, Michael; Agarwal, Atul; Deshpande, Milind

Agent Cullen & Co

Pub. Number AU-A-2005304646

PCT Pub. Number WO2006/053323

Priority 60/626,902 11.11.04 US

Filing date 10 November 2005

Wipo publication date 18 May 2006

International Classifications

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61K 31/4353 (2006.01) - ortho- or peri-condensed with heterocyclic ring systems

Event Publications

14 June 2007 PCT application entered the National Phase

  PCT publication WO2006/053323 Priority application(s): WO2006/053323

5 November 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005304650-Cartons having tilt features

2005304645-Compositions and methods for inferring an adverse effect in response to a drug treatment